bioRxiv · 10.1101/731943
Structure-activity relationship studies of three novel 4-aminopyridine K+ channel blockers
Abstract
4-Aminopyridine (4AP) is a specific blocker of voltage-gated potassium channels (KV1 family) clinically approved for the symptomatic treatment of patients with multiple sclerosis (MS). It has recently been shown that [18F]3F4AP, a radiofluorinated analog of 4AP, also binds to KV1 channels and can be used as a PET tracer for the detection of demyelinated lesions in rodent models of MS. Here, we investigate three novel 4AP derivatives containing methyl (-CH3), methoxy (-OCH3) and trifluoromethyl (-CF3) in the 3 position as potential candidates for PET imaging and/or therapy. We characterized the physicochemical properties of these compounds (pKa and logD) and analyzed their ability to block Shaker K+ channel under different voltage and pH conditions. Our results demonstrate that all three derivatives are able to block voltage-gated potassium channels. Specifically, 3-methyl-4-aminopyridine (3Me4AP) was found to be approximately 7-fold more potent than 4AP, whereas the methoxy (3MeO4AP) and trifluoromethyl (3CF34AP) containing compounds were about 3- to 4-fold less potent than 4AP, respectively. These results suggest that these novel derivatives are potential candidates for therapy and imaging.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Rodriguez-Rangel, S., Bravin, A. D., Ramos-Torres, K. M., Brugarolas, P., Sanchez-Rodriguez, J. E.. 2019-08-11. Structure-activity relationship studies of three novel 4-aminopyridine K+ channel blockers. https://doi.org/10.1101/731943
Cite the original work for its findings. Save a collection to share your selection of sources.